美股A股
StockGist
Back to EXLS
Q2 20262026-07-28· deepseek:deepseek-v4-flash

EXLS earnings call summary

Prepared Highlights

Official guidance

Mgmt quotes

Prepared Metrics

MetricValueSpeaker/Context
Q2 2026营收$594.8M(CFO),同比+15.6%报告/+15.9%固定汇率
Q2 2026调整后EPS$0.59(CFO),同比+22.3%
Q2调整后经营利润率19.7%(CFO),同比+10 bps
Q2 SG&A/营收20.9%(CFO),同比+170 bps
Q2有效税率21.3%(CFO),同比-110 bps
Insurance营收$197.8M(CFO),同比+14.9%
Healthcare and Life Sciences营收$158.0M(CFO),同比+22%,环比+4%
Banking, Capital Markets and Diversified Industries营收$133.9M(CFO),同比+10.7%,环比+5.1%
International Growth Markets营收$105.1M(CFO),同比+16.3%,环比+8.9%
1H 2026营收$1.17B(CFO),同比+14.7%
1H 2026调整后经营利润率20.1%(CFO),同比+20 bps
1H 2026调整后EPS$1.17(CFO),同比+21.3%
现金及长短期投资$284M(CFO),截至2026-06-30
循环贷款债务$381M(CFO),净债务$97M
1H经营现金流$90M(CFO)
1H资本开支$27M(CFO)
1H回购5.8M股,均价$30.90,合计$179M(CFO),含ASR 4.15M股@$30.10
2026营收指引$2.39B–$2.415B(CEO/CFO),同比+14%–+16%报告
2026调整后EPS指引$2.25–$2.29(CEO/CFO),同比+16%–+18%
2026资本开支指引$58M–$62M(CFO)

Q&A Batch (1-5 of 6)

Q1 — Bryan Bergin

Q2 — Surinder Thind

Q3 — Puneet Jain

Q4 — Margaret Nolan

Q5 — David Grossman

Q&A Batch (6-6 of 6)

Q6 — Vincent Colicchio / David Koning